Therapeutics News and Research

RSS

Unlocking the power of proteins to better understand human health

We speak to Andrew Lynn, the chief executive at Fluidic Analytics, about the role proteins play in understanding human disease.

From Fluidic Analytics 21 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 21 Jul 2022

Study offers insight into the basic cellular pathologies driving interstitial lung disease

While most people recover from COVID-19 within a week or two, up to one-third of survivors experience persistent or new symptoms weeks and months after initial infection.

21 Jul 2022

High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

Researchers evaluates the sensitivity of BA.4 in both vaccinated and unvaccinated individuals infected with the SARS-CoV-2 variants.

20 Jul 2022

Nanotherapeutic compound may help treat inflammation, brain injury in patients with severe COVID-19

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from UTHealth Houston and other institutions.

20 Jul 2022

Hypertension linked to double the risk of severe COVID-19 despite booster vaccination

Having high blood pressure more than doubled a person's risk for hospitalization from an Omicron-variant COVID-19 infection - even despite full vaccination including a booster dose of the COVID-19 vaccines, in an analysis of adults hospitalized with COVID-19 in Los Angeles between December 2021 and April 2022, according to new research published today in Hypertension, an American Heart Association journal.

20 Jul 2022

Study finds significant evidence for inaccurate and misleading labeling of CBD content

In a new study, Johns Hopkins Medicine researchers tested more than 100 topical cannabidiol (CBD) products available online and at retail stores, and found significant evidence of inaccurate and misleading labeling of CBD content.

20 Jul 2022

What is the role of a niclosamide-based organic/inorganic hybrid in the suppression of SARS-CoV-2 infections?

A new study involved the preparation of NIC-MgO and NIC-MgO-HPMC by solid-state intercalation reaction followed by cetrimonium bromide (CTAB) stabilized NIC-MgO and MgO Nanoparticles (NP) preparation.

20 Jul 2022

Researchers report the detection of viral mutations associated with drug resistance in patients treated with REGEN-COV and sotrovimab

Researchers reported mutations in SARS-CoV-2 Delta and Omicron variants of concern infection cases treated with neutralizing monoclonal antibodies.

20 Jul 2022

Scientists find new evidence against using BET inhibitors to treat COVID-19

A while ago, some researchers had suggested that blocking a set of proteins, known as bromodomain and extraterminal (BET) proteins, might be a way to fight COVID-19.

20 Jul 2022

Scientists manipulate good bacteria using CRISPR systems

New North Carolina State University research shows progress in gathering information on an important – yet difficult to characterize – human gut bacterium called Bifidobacterium, which is used in many probiotics that help maintain healthy microbiomes.

19 Jul 2022

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

A new study involving hospitalized women in six African countries from the University of Maryland School of Medicine's (UMSOM) Institute of Human Virology (IHV) showed that pregnant women with SARS-CoV-2, the virus that causes COVID-19, had double the risk of being admitted to the intensive care unit (ICU) and four-times the risk of dying in-hospital than pregnant women who did not have COVID-19.

19 Jul 2022

Anti-rejection drug plus immunotherapy could change the lives of kidney transplant patients with cancer

Adding immunotherapy to standard anti-rejection medication could change the lives of thousands of kidney transplant patients with incurable cancer, as new research shows it can reduce this risk of organ rejection and eliminate cancer in a quarter of patients.

18 Jul 2022

Conservative blocs unleash litigation to curb public health powers

Through a wave of pandemic-related litigation, a trio of small but mighty conservative legal blocs has rolled back public health authority at the local, state, and federal levels, recasting America's future battles against infectious diseases.

18 Jul 2022

Researchers develop a rapid, specific, and accurate RT-qPCR-based method to detect and distinguish between Omicron sublineages

Researchers developed a novel, rapid and accurate qRT-PCR-based method to detect Omicron sublineages BA.1/BA.1.1 and BA.2 in patient samples.

18 Jul 2022

Therapeutics News and Research

Unlocking the power of proteins to better understand human health

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Study offers insight into the basic cellular pathologies driving interstitial lung disease

High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

Nanotherapeutic compound may help treat inflammation, brain injury in patients with severe COVID-19

Hypertension linked to double the risk of severe COVID-19 despite booster vaccination

Study finds significant evidence for inaccurate and misleading labeling of CBD content

What is the role of a niclosamide-based organic/inorganic hybrid in the suppression of SARS-CoV-2 infections?

Researchers report the detection of viral mutations associated with drug resistance in patients treated with REGEN-COV and sotrovimab

Scientists find new evidence against using BET inhibitors to treat COVID-19

Scientists manipulate good bacteria using CRISPR systems

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

Anti-rejection drug plus immunotherapy could change the lives of kidney transplant patients with cancer

Conservative blocs unleash litigation to curb public health powers

Researchers develop a rapid, specific, and accurate RT-qPCR-based method to detect and distinguish between Omicron sublineages

The characteristics of circulating T follicular helper cells in COVID-19 patients across mild to severe disease

The state of antimicrobial resistance in the United States immediately following the 2020 peaks of the COVID-19 pandemic

Novel nanoligomer approach to treat severe COVID-19

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

Alcohol consumption does not provide any health benefits, presents many risks for young people

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News